--- /home/parlparse/parldata/cmpages/wrans/answers2006-06-27a.html	2006-06-28 09:14:27.645135267 +0100
+++ /home/parlparse/parldata/tmp/patchtmp-answers2006-06-27a-rqRez4.html	2006-06-28 09:16:30.218828771 +0100
@@ -1,110 +1,7 @@
 <pagex url="http://www.publications.parliament.uk/pa/cm200506/cmhansrd/cm060627/index/60627-x.htm" scrapedate="2006-06-28" scrapetime="08:14:23" type="printed" />
 <page url="http://www.publications.parliament.uk/pa/cm200506/cmhansrd/cm060626/text/60626w1227.htm"/>
 
-
-<h3 align="center"><a name="06062726000053">Rheumatoid
-Arthritis</h3><p><a name="06062726000328"><b><a name="06062726000477">Mrs.
-Dean:</b> To ask the Secretary of State for
-Health what representations her Department made to the European
-Commission regarding the inclusion of rheumatoid arthritis as a
-priority area of EU Framework Programme 7.
-[79177]</p><p><a name="06062726000329"><b><a name="06062726000478">Andy
-Burnham:</b> At the Competitiveness Council held on 30 May
-2006, a general approach was agreed on the seventh framework programme
-high level text. A general approach is a political agreement, which
-allows Ministers to agree in principle to a text that has yet to be
-considered by the European Parliament. The United Kingdom Government
-have supported the inclusion of arthritis as one of the priority
-diseases named in the agreed
-text.</p><h3 align="center"><a name="06062726000054">Spinal Cord
-Injuries</h3><p><a name="06062726000330"><b><a name="06062726000479">Mr.
-Lansley:</b> To ask the Secretary of State for
-Health what consideration she has given to the merits of establishing a
-national clinical director for spinal cord injury.
-[80342]</p><p><a name="06062726000331"><b><a name="06062726000480">Mr.
-Ivan Lewis:</b> None. Primary care trusts are responsible for
-commissioning specialist services through specialised commissioning
-groups, and the national service framework for long-term conditions is
-specifically concerned with meeting the health and social care needs of
-all those living with long-term neurological
-conditions.</p><h3 align="center"><a name="06062726000055">Strategic
-Health
-Authorities</h3><p><a name="06062726000332"><b><a name="06062726000481">Mr.
-Kidney:</b> To ask the Secretary of State for
-Health if she will summarise the representations she received in
-response to the consultations on <i> (a)</i> strategic health
-authorities, <i> (b)</i> primary care trusts and <i> (c)</i> ambulance
-services; and how many she received (i) in total and (ii) from
-Staffordshire.
-[76751]</p><p><a name="06062726000333"><b><a name="06062726000482">Mr.
-Ivan Lewis:</b> 1,030 separate letters were sent to Ministers,
-including the Secretary of State, during the consultation period on
-strategic health authority and primary care trusts reconfiguration. Of
-these, 11 were specific to
-Staffordshire.</p><p><a name="06062726000334">261
-separate letters were sent to Ministers, including the Secretary of
-State, during the consultation period on ambulance trust configuration.
-Of these, 192 concerned Staffordshire Ambulance Service NHS Trust and
-eight of these letters enclosed petitions totalling 2,946 signatures.
-In addition, Ministers met with a number of hon. Members during that
-time.</p><br><notus-date day="26" month="6" year="2006" textMonth="Jun"></notus-date><b>26 Jun 2006 : Column 239W</b><br><h3 align="center"><a name="06062726000056">Sunitinib</h3><p><a name="06062726000335"><b><a name="06062726000483">Mr.
-Keetch:</b> To ask the Secretary of State for
-Health when she expects the National Institute for Health and Clinical
-Excellence to commence appraisal for the cancer drug Sunitinib; and how
-long the appraisal is expected to last.
-[79333]</p><p><a name="06062726000336"><b><a name="06062726000484">Andy
-Burnham:</b> Sunitinib for renal cell carcinoma is currently
-being considered by the Department for referral to the National
-Institute for Health and Clinical Excellence (NICE). NICE will publish
-a timescale for the appraisal when and if the drug is referred to
-them.</p><h3 align="center"><a name="06062726000057">Tuberculosis</h3><p><a name="06062726000337"><b><a name="06062726000485">Mr.
-Stephen O'Brien:</b> To ask the Secretary of
-State for Health what assessment she has made of the risk to NHS
-professionals of litigation arising from <i> (a)</i> misdiagnosis and
-<i> (b)</i> medical complications when using the Mantoux skin test for
-tuberculosis.
-[76381]</p><p><a name="06062726000338"><b><a name="06062726000486">Andy
-Burnham:</b> The tuberculin product used in the United Kingdom
-(UK) is the most widely used product for Mantoux testing and is the
-World Health Organization reference standard. This product is currently
-unlicensed in the UK and can, therefore, only be administered on a
-named patient basis via a patient specific
-direction.</p><p><a name="06062726000339">Doctors
-prescribe or administer unlicensed medicines to their patients on their
-own direct responsibility. Unlicensed medicines can be administered by
-other national health service professionals on the directions of a
-doctor but the doctor remains responsible for the 
-<br><notus-date day="26" month="6" year="2006" textMonth="Jun"></notus-date><b>26 Jun 2006 : Column 240W</b><br>decision to give the unlicensed product for the individual concerned. A
-claim can be brought against a doctor who prescribes or administers any
-medicine, whether licensed or unlicensed, if the patient can show that
-the doctor acted negligently. NHS professionals are required to have in
-place appropriate professional negligence insurance in respect of such
-claims.</p><h3 align="center"><a name="06062726000058">United Health
-Europe</h3><p><a name="06062726000340"><b><a name="06062726000487">Steve
-Webb:</b> To ask the Secretary of State for
-Health if she will list the contracts that have been awarded in the UK
-by <i> (a)</i> the Government and <i> (b)</i> primary care trusts to
-United Health Europe; and if she will make a statement.
-[53684]</p><p><a name="06062726000341"><b><a name="06062726000488">Mr.
-Ivan Lewis:</b> One contract has been made between the
-Department and United Health Europe. This contract is for project
-management of nine primary care trust (PCT) pilots for improving the
-co-ordination of cancer care
-services.</p><p><a name="06062726000342">The
-Department does not collect information about contracts which are
-agreed locally between PCTs and providers or which are within the
-purview of the devolved
-Administrations.</p><h3 align="center"><a name="06062726000059">Waiting
-Times</h3><p><a name="06062726000343"><b><a name="06062726000489">Mr.
-Bone:</b> To ask the Secretary of State for
-Health how many people had been waiting more than six months for an NHS
-in-patient operation in England at the end of <i> (a)</i> April and
-<i> (b)</i> May.
-[77693]</p><p><a name="06062726000344"><b><a name="06062726000490">Andy
-Burnham:</b> The number of patients waiting over six months at
-the end of April 2006 was 144. The figures relating to the end of May
-2006 will be published on 30
-June.</p><br><notus-date day="27" month="6" year="2006" textMonth="Jun"></notus-date><b>27 Jun 2006 : Column 241W</b><br><h2 align="center"><a name="06062726000002">Written Answers
+<br><notus-date day="27" month="6" year="2006" textMonth="Jun"></notus-date><b>27 Jun 2006 : Column 241W</b><br><h2 align="center"><a name="06062726000002">Written Answers
 to Questions</h2><h4 align="center"><a name="06062726000005"><i> Tuesday
 27 June
 2006</i></h4><h3 align="center" style="text-transform:uppercase"><a name="06062734000001">Environment,
